tiprankstipranks
Advertisement
Advertisement

GB:GENI Stock Latest News

GENinCode Sets June Dates to Present 2025 Audited Results to Market
Company AnnouncementsGENinCode Sets June Dates to Present 2025 Audited Results to Market
4d ago
GENinCode Resets Share Option Plan to Align Incentives With Current Valuation
PremiumCompany Announcements
GENinCode Resets Share Option Plan to Align Incentives With Current Valuation
19d ago
GENinCode wins shareholder backing for major share issue as directors join fundraising
PremiumCompany Announcements
GENinCode wins shareholder backing for major share issue as directors join fundraising
4M ago
GENinCode Lifts Fundraise to £4.7m After Strong Investor Demand
PremiumCompany Announcements
GENinCode Lifts Fundraise to £4.7m After Strong Investor Demand
4M ago
GENinCode Raises £4.1m Following Completion of WRAP Retail Offer
PremiumCompany Announcements
GENinCode Raises £4.1m Following Completion of WRAP Retail Offer
4M ago
GENinCode Raises £3.9m via Discounted Placing and Director-Backed Subscription
PremiumCompany AnnouncementsGENinCode Raises £3.9m via Discounted Placing and Director-Backed Subscription
4M ago
GENinCode Opens WRAP Retail Offer Alongside £3.5m Placing at Deep Discount
Premium
Company Announcements
GENinCode Opens WRAP Retail Offer Alongside £3.5m Placing at Deep Discount
4M ago
GENinCode Launches Discounted £3.5m Fundraise to Back US and European Expansion
Premium
Company Announcements
GENinCode Launches Discounted £3.5m Fundraise to Back US and European Expansion
4M ago
GENinCode Partners with Sohin Genetics to Distribute Heart Disease Risk Test in Mexico
PremiumCompany Announcements
GENinCode Partners with Sohin Genetics to Distribute Heart Disease Risk Test in Mexico
5M ago
GENinCode Partners with Thermo Fisher for CARDIO inCode-Score® Expansion
PremiumCompany Announcements
GENinCode Partners with Thermo Fisher for CARDIO inCode-Score® Expansion
6M ago
GENinCode’s CARDIO inCode-Score® Test Gains New York State Approval
PremiumCompany Announcements
GENinCode’s CARDIO inCode-Score® Test Gains New York State Approval
6M ago
GENinCode’s CARDIO inCode-Score® Validated for Enhanced Heart Disease Risk Prediction
PremiumCompany Announcements
GENinCode’s CARDIO inCode-Score® Validated for Enhanced Heart Disease Risk Prediction
7M ago
GENinCode Reports Revenue Growth Amid Strategic Expansions and Challenges
PremiumCompany AnnouncementsGENinCode Reports Revenue Growth Amid Strategic Expansions and Challenges
8M ago
GENinCode and NHS Launch ROCA Surveillance Service for Ovarian Cancer
Premium
Company Announcements
GENinCode and NHS Launch ROCA Surveillance Service for Ovarian Cancer
8M ago
GENinCode Plc Observes Unexpected Share Price Movement Amid Ongoing FDA Discussions
Premium
Company Announcements
GENinCode Plc Observes Unexpected Share Price Movement Amid Ongoing FDA Discussions
8M ago
GENinCode to Release Interim Results and Host Investor Briefing
PremiumCompany Announcements
GENinCode to Release Interim Results and Host Investor Briefing
9M ago
GENinCode Reports Revenue Growth and Advances Strategic Initiatives in H1 2025
PremiumCompany Announcements
GENinCode Reports Revenue Growth and Advances Strategic Initiatives in H1 2025
9M ago
GENinCode Updates on FDA De Novo Submission Progress
PremiumCompany Announcements
GENinCode Updates on FDA De Novo Submission Progress
11M ago
GENinCode Plc Successfully Passes All Resolutions at AGM
PremiumCompany Announcements
GENinCode Plc Successfully Passes All Resolutions at AGM
11M ago
GENinCode Plc Reports 25% Revenue Growth and Expands US Market Presence
PremiumCompany AnnouncementsGENinCode Plc Reports 25% Revenue Growth and Expands US Market Presence
12M ago
GENinCode Announces Release Date for 2024 Financial Results
Premium
Company Announcements
GENinCode Announces Release Date for 2024 Financial Results
1y ago
GENinCode Plc Grants Share Options to Boost Staff Retention
Premium
Company Announcements
GENinCode Plc Grants Share Options to Boost Staff Retention
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >